|
SECTION 1 PHYSIOLOGY OF BLOOD |
|
|
|
Chapter 1 Overview of Physiology of Blood |
|
|
1 | (51) |
|
|
|
1 | (5) |
|
|
|
6 | (9) |
|
|
|
15 | (12) |
|
|
|
27 | (5) |
|
|
|
32 | (1) |
|
|
|
33 | (19) |
|
SECTION 2 DISORDERS OF RED BLOOD CELLS (ANAEMIAS) |
|
|
|
Chapter 2 Approach to Diagnosis of Anaemias |
|
|
52 | (19) |
|
|
|
53 | (18) |
|
Chapter 3 Anaemias Due to Impaired Red Cell Production |
|
|
71 | (50) |
|
|
|
71 | (1) |
|
|
|
71 | (4) |
|
Causes of Iron Deficiency Anaemia |
|
|
75 | (1) |
|
|
|
76 | (1) |
|
|
|
76 | (5) |
|
|
|
81 | (1) |
|
Treatment of Iron Deficiency Anaemia |
|
|
81 | (2) |
|
|
|
83 | (1) |
|
Normal Vitamin 12 Metabolism |
|
|
83 | (3) |
|
|
|
86 | (1) |
|
General Morphological Features of Megaloblastic Anaemia |
|
|
86 | (1) |
|
Causes of Megaloblastic Anaemia |
|
|
86 | (11) |
|
Aplastic Anaemia and Related Disorders |
|
|
97 | (1) |
|
Acquired Aplastic Anaemia |
|
|
98 | (8) |
|
Constitutional Aplastic Anaemia |
|
|
106 | (1) |
|
|
|
107 | (1) |
|
Anaemia of Chronic Disorders |
|
|
108 | (1) |
|
|
|
109 | (1) |
|
|
|
110 | (1) |
|
|
|
110 | (1) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
112 | (1) |
|
|
|
112 | (2) |
|
Anaemia of Chronic Renal Failure |
|
|
114 | (1) |
|
|
|
114 | (1) |
|
Clinical and Laboratory Features |
|
|
115 | (1) |
|
|
|
115 | (1) |
|
|
|
115 | (1) |
|
|
|
116 | (1) |
|
Congenital Dyserythropoietic Anaemias (CDA) |
|
|
116 | (1) |
|
|
|
117 | (1) |
|
|
|
117 | (1) |
|
|
|
118 | (3) |
|
Chapter 4 Anaemias Due to Excessive Red Cell Destruction |
|
|
121 | (103) |
|
|
|
121 | (1) |
|
|
|
121 | (1) |
|
|
|
122 | (1) |
|
|
|
122 | (1) |
|
|
|
123 | (4) |
|
Diagnosis of Hereditary Spherocytosis |
|
|
127 | (1) |
|
|
|
127 | (1) |
|
|
|
128 | (1) |
|
Hereditary Disorders of Haemoglobin |
|
|
128 | (1) |
|
General Features and Approach to Diagnosis |
|
|
128 | (13) |
|
|
|
141 | (30) |
|
|
|
171 | (14) |
|
Disorders of Red Cell Enzymes |
|
|
185 | (1) |
|
Glucose-6-Phosphate Dehydrogenase Deficiency |
|
|
185 | (7) |
|
Immune Haemolytic Anaemias |
|
|
192 | (1) |
|
|
|
192 | (10) |
|
Haemolytic Disease of the Newborn |
|
|
202 | (1) |
|
Rh Haemolytic Disease of the Newborn |
|
|
203 | (6) |
|
ABO Haemolytic Disease of Newborn |
|
|
209 | (1) |
|
Paroxysmal Nocturnal Haemoglobinuria |
|
|
210 | (1) |
|
|
|
210 | (2) |
|
|
|
212 | (1) |
|
|
|
212 | (3) |
|
|
|
215 | (1) |
|
|
|
215 | (1) |
|
Mechanical Haemolytic Anaemias |
|
|
216 | (1) |
|
Microangiopathic Haemolytic Anaemia |
|
|
216 | (1) |
|
|
|
217 | (1) |
|
Cardiac Haemolytic Anaemia |
|
|
217 | (1) |
|
Haemolytic Anaemia Due to Direct Action of Physical, Chemical, or Infectious Agents |
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
218 | (1) |
|
Normal Structure and Function of Spleen |
|
|
218 | (1) |
|
|
|
219 | (1) |
|
|
|
219 | (5) |
|
SECTION 3 DISORDERS OF WHITE BLOOD CELLS |
|
|
|
Chapter 5 Acute Leukaemias |
|
|
224 | (43) |
|
Diagnosis and Classification |
|
|
224 | (17) |
|
Acute Lymphoblastic Leukaemia |
|
|
241 | (11) |
|
|
|
252 | (15) |
|
Chapter 6 Myelodysplastic Syndromes |
|
|
267 | (10) |
|
|
|
267 | (1) |
|
|
|
268 | (1) |
|
|
|
269 | (1) |
|
|
|
269 | (4) |
|
|
|
273 | (1) |
|
|
|
274 | (1) |
|
|
|
274 | (3) |
|
Chapter 7 Myeloproliferative Neoplasms |
|
|
277 | (22) |
|
|
|
278 | (1) |
|
Chronic Myeloid Leukaemia |
|
|
278 | (11) |
|
|
|
289 | (5) |
|
Primary Myelofibrosis (PMF) |
|
|
294 | (2) |
|
Essential Thrombocythaemia |
|
|
296 | (3) |
|
Chapter 8 Chronic Lymphoid Leukaemias |
|
|
299 | (13) |
|
Chronic Lymphocytic Leukaemia |
|
|
299 | (7) |
|
|
|
306 | (2) |
|
|
|
308 | (4) |
|
Chapter 9 Plasma Cell Dyscrasias |
|
|
312 | (23) |
|
Investigations in Plasma Cell Dyscrasias |
|
|
312 | (6) |
|
|
|
318 | (11) |
|
Waldenstrom's Macroglobulinaemia |
|
|
329 | (3) |
|
Monoclonal Gammopathy of Undetermined Significance |
|
|
332 | (3) |
|
Chapter 10 Malignant Lymphomas |
|
|
335 | (16) |
|
|
|
336 | (4) |
|
|
|
340 | (11) |
|
Chapter 11 Quantitative and Qualitative Disorders of Leucocytes |
|
|
|
Disorders of Granulocytes |
|
|
351 | (1) |
|
|
|
351 | (2) |
|
Leucoerythroblastic Reaction |
|
|
353 | (1) |
|
|
|
353 | (1) |
|
|
|
354 | (2) |
|
|
|
356 | (1) |
|
|
|
357 | (1) |
|
Disorders of Phagocytic Leucocytes Characterised by Morphologic Changes |
|
|
357 | (3) |
|
Disorders of Monocyte Macrophage System |
|
|
360 | (1) |
|
|
|
360 | (1) |
|
|
|
361 | (3) |
|
|
|
364 | (1) |
|
|
|
365 | (4) |
|
Immunodeficiency Diseases |
|
|
369 | (1) |
|
Classification of Immunodeficiency Diseases |
|
|
370 | (5) |
|
Chapter 12 Haematopoietic Stem Cell Transplantation |
|
|
375 | (7) |
|
Types of Haematopoietic Stem Cell Transplantation (HSCT) |
|
|
375 | (5) |
|
Sources of Haematopoietic Stem Cells |
|
|
380 | (1) |
|
|
|
380 | (2) |
|
SECTION 4 DISORDERS OF HAEMOSTASIS |
|
|
|
Chapter 13 Approach to the Diagnosis of Bleeding Disorders |
|
|
382 | (17) |
|
|
|
382 | (3) |
|
|
|
385 | (1) |
|
|
|
385 | (6) |
|
|
|
391 | (8) |
|
Chapter 14 Bleeding Disorders Caused by Abnormalities of Blood Vessels (The Vascular Purpuras) |
|
|
399 | (3) |
|
Anaphylactoid Purpura (Henoch-Schonlein Purpura, Allergic Purpura) |
|
|
400 | (1) |
|
|
|
400 | (1) |
|
|
|
400 | (1) |
|
|
|
400 | (1) |
|
|
|
401 | (1) |
|
|
|
401 | (1) |
|
Hereditary Haemorrhagic Telangiectasia (Osler-Weber-Rendu Disease) |
|
|
401 | (1) |
|
Chapter 15 Bleeding Disorders Caused by Abnormalities of Platelets |
|
|
402 | (18) |
|
|
|
402 | (11) |
|
|
|
413 | (1) |
|
Disorders of Platelet Function |
|
|
414 | (6) |
|
Chapter 16 Disorders of Coagulation |
|
|
420 | (36) |
|
Inherited Disorders of Coagulation |
|
|
420 | (1) |
|
|
|
420 | (12) |
|
|
|
432 | (6) |
|
|
|
438 | (1) |
|
Inherited Disorders of Fibrinogen |
|
|
439 | (1) |
|
Acquired Disorders of Coagulation |
|
|
440 | (1) |
|
|
|
440 | (1) |
|
Liver Disease (Cirrhosis of Liver) |
|
|
441 | (1) |
|
Disseminated Intravascular Coagulation |
|
|
442 | (5) |
|
Acquired Inhibitors of Coagulation (Circulating Anticoagulants) |
|
|
447 | (3) |
|
|
|
450 | (1) |
|
|
|
451 | (2) |
|
Other Acquired Coagulation Disorders |
|
|
453 | (3) |
|
SECTION 5 BLOOD TRANSFUSION |
|
|
|
Chapter 17 Blood Group Systems |
|
|
456 | (7) |
|
|
|
457 | (3) |
|
|
|
460 | (3) |
|
Chapter 18 Serologic and Microbiologic Techniques |
|
|
463 | (14) |
|
|
|
463 | (10) |
|
|
|
473 | (4) |
|
Chapter 19 Collection of Donor Blood, Processing and Storage |
|
|
477 | (9) |
|
|
|
477 | (1) |
|
Criteria for Selection of Blood Donors |
|
|
478 | (4) |
|
Collection of Donor Blood |
|
|
482 | (2) |
|
Processing of Donor Blood |
|
|
484 | (1) |
|
Storage of Donor Blood Unit |
|
|
484 | (2) |
|
Chapter 20 Whole Blood, Blood Components and Blood Derivatives |
|
|
486 | (11) |
|
|
|
487 | (2) |
|
|
|
489 | (6) |
|
|
|
495 | (2) |
|
Chapter 21 Transfusion of Blood to the Recipient |
|
|
497 | (5) |
|
Selection of Donor Blood for Whole Blood or Packed Red Cell Transfusion |
|
|
498 | (1) |
|
Selection of Donor Plasma |
|
|
499 | (1) |
|
Antibody Screening and Identification |
|
|
499 | (1) |
|
|
|
499 | (1) |
|
Issue of Donor Blood Unit |
|
|
499 | (1) |
|
Transfusion of Blood Unit |
|
|
500 | (2) |
|
Chapter 22 Adverse Effects of Transfusion |
|
|
502 | (11) |
|
|
|
503 | (4) |
|
|
|
507 | (5) |
|
Complications Associated with Massive Blood Transfusion |
|
|
512 | (1) |
|
Chapter 23 Autologous Transfusion |
|
|
513 | (3) |
|
Predeposit Autologous Blood Transfusion |
|
|
513 | (1) |
|
Acute Normovolaemic Haemodilution |
|
|
514 | (1) |
|
|
|
515 | (1) |
|
Chapter 24 Alternatives to Blood Transfusion |
|
|
516 | (3) |
|
Haematopoietic Growth Factors (HGFs) |
|
|
517 | (1) |
|
|
|
517 | (2) |
|
|
|
|
Appendix A Reference Ranges |
|
|
519 | (3) |
|
Appendix B Selected CD Antigens |
|
|
522 | (3) |
|
Appendix C Critical Values in Haematology |
|
|
525 | (2) |
| Suggested Reading |
|
527 | (4) |
| Index |
|
531 | |
